- Home
- PASW vs MBRX Comparison
PASW vs MBRX Comparison
Compare PASW & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASW
- MBRX
- Stock Information
- Founded
- PASW 2021
- MBRX 2015
- Country
- PASW Hong Kong
- MBRX United States
- Employees
- PASW N/A
- MBRX N/A
- Industry
- PASW Apparel
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- PASW Consumer Discretionary
- MBRX Health Care
- Exchange
- PASW Nasdaq
- MBRX Nasdaq
- Market Cap
- PASW 20.3M
- MBRX 24.3M
- IPO Year
- PASW N/A
- MBRX 2016
- Fundamental
- Price
- PASW $1.01
- MBRX $0.48
- Analyst Decision
- PASW
- MBRX Strong Buy
- Analyst Count
- PASW 0
- MBRX 4
- Target Price
- PASW N/A
- MBRX $5.00
- AVG Volume (30 Days)
- PASW 2.8M
- MBRX 2.8M
- Earning Date
- PASW 11-15-2025
- MBRX 11-07-2025
- Dividend Yield
- PASW N/A
- MBRX N/A
- EPS Growth
- PASW N/A
- MBRX N/A
- EPS
- PASW N/A
- MBRX N/A
- Revenue
- PASW $8,286,193.00
- MBRX N/A
- Revenue This Year
- PASW N/A
- MBRX N/A
- Revenue Next Year
- PASW N/A
- MBRX N/A
- P/E Ratio
- PASW N/A
- MBRX N/A
- Revenue Growth
- PASW N/A
- MBRX N/A
- 52 Week Low
- PASW $0.89
- MBRX $0.25
- 52 Week High
- PASW $5.40
- MBRX $3.65
- Technical
- Relative Strength Index (RSI)
- PASW N/A
- MBRX 53.68
- Support Level
- PASW N/A
- MBRX $0.42
- Resistance Level
- PASW N/A
- MBRX $0.55
- Average True Range (ATR)
- PASW 0.00
- MBRX 0.04
- MACD
- PASW 0.00
- MBRX 0.01
- Stochastic Oscillator
- PASW 0.00
- MBRX 59.68
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.